Spanish startup Impress raises $125 million in a Series B funding round to enhance its innovative orthodontic solutions across Europe.

Information on the Target

Impress, a Spanish startup founded in 2019 in Barcelona, has revolutionized the field of invisible orthodontics. The company specializes in developing transparent aligners as an alternative to traditional braces, utilizing AI-assisted 3D scanning to customize aligners for each patient. Impress provides a comprehensive orthodontic experience that combines cutting-edge technology with personalized care, allowing for continuous digital monitoring and support by qualified medical professionals.

Since its inception, Impress has rapidly expanded its operations, establishing a network of clinics across more than 130 cities in eight European countries. This impressive growth trajectory is bolstered by the startup’s commitment to innovation and customer service, enabling them to adapt to the evolving needs of patients in the healthcare industry.

Industry Overview in Spain

The orthodontic and dental care market in Spain has experienced significant growth in recent years, driven by rising consumer awareness of dental aesthetics and advancements in orthodontic technology.

View Source

Similar Deals

Bpifrance ARTHEx Biotech S.L.

2025

Series B Bio Therapeutic Drugs Spain
FinTLV Ventures and Korelya Capital ifeel

2024

Series B Healthcare Facilities & Services (NEC) Spain
Edmond de Rothschild Investment Partners MedLumics

2017

Series B Advanced Medical Equipment & Technology (NEC) Spain
Kurma Life Sciences Partners STAT-Diagnostica

2013

Series B Bio Diagnostics & Testing Spain
Ysios Asset Management Cellerix

2007

Series B Bio Therapeutic Drugs Spain

Impress

invested in

Impress

in 2023

in a Series B deal

Disclosed details

Transaction Size: $125M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert